Activity of the neuronal cold sensor TRPM8 is regulated by phospholipase C via the phospholipid phosphoinositol 4,5-bisphosphate.
Cold temperatures robustly activate a small cohort of somatosensory nerves, yet during a prolonged cold stimulus their activity will decrease, or adapt, over time. This process allows for the discrimination of subtle changes in temperature. At the molecular level, cold is detected by transient receptor potential melastatin 8 (TRPM8), a nonselective cation channel expressed on a subset of peripheral afferent fibers. We and others have reported that TRPM8 channels also adapt in a calcium-dependent manner when activated by the cooling compound menthol. Additionally, TRPM8 activity is sensitive to the phospholipid phosphoinositol 4,5-bisphosphate (PIP2), a substrate for the enzyme phospholipase C (PLC). These results suggest an adaptation model whereby TRPM8-mediated Ca2+ influx activates PLC, thereby decreasing PIP2 levels and resulting in reduced TRPM8 activity. Here we tested this model using pharmacological activation of PLC and by manipulating PIP2 levels independent of both PLC and Ca2+. PLC activation leads to adaptation-like reductions in cold- or menthol-evoked TRPM8 currents in both heterologous and native cells. Moreover, PLC-independent reductions in PIP2 had a similar effect on cold- and menthol-evoked currents. Mechanistically, either form of adaptation does not alter temperature sensitivity of TRPM8 but does lead to a change in channel gating. Our results show that adaptation is a shift in voltage dependence toward more positive potentials, reversing the trend toward negative potentials caused by agonist. These data suggest that PLC activity not only mediates adaptation to thermal stimuli, but likely underlies a more general mechanism that establishes the temperature sensitivity of somatosensory neurons.
Daniels
Richard L
RL
Neuroscience Graduate Program, Neurobiology Section, Department of Biological Sciences, University of Southern California, Los Angeles, California 90089, USA.
Takashima
Yoshio
Y
McKemy
David D
DD
D000222:Adaptation, Physiological / Q000187:drug effects / Q000502:physiology; D000818:Animals; D000982:Antipruritics / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism; D003080:Cold Temperature; D005073:Evoked Potentials, Somatosensory / Q000187:drug effects / Q000502:physiology*; D008610:Menthol / Q000494:pharmacology; D051379:Mice; D008822:Mice, Transgenic; D009475:Neurons, Afferent / Q000378:metabolism*; D019269:Phosphatidylinositol 4,5-Diphosphate / Q000235:genetics / Q000378:metabolism*; D054801:Phosphoinositide Phospholipase C / Q000235:genetics / Q000378:metabolism*; D050053:TRPM Cation Channels / Q000235:genetics / Q000378:metabolism*; D014982:Xenopus laevis
D000982:Antipruritics; D019269:Phosphatidylinositol 4,5-Diphosphate; D050053:TRPM Cation Channels; C492297:TRPM8 protein, mouse; D008610:Menthol; D054801:Phosphoinositide Phospholipase C; D002118:Calcium